PuraPharm Corp. Ltd. ( (HK:1498) ) just unveiled an update.
PuraPharm Corporation Limited has announced an upcoming board meeting scheduled for March 27, 2025. The meeting will focus on approving the annual results for the year ending December 31, 2024, and considering the payment of a final dividend, which could impact the company’s financial strategy and shareholder returns.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company, along with its subsidiaries, is involved in the development and distribution of traditional Chinese medicine products.
YTD Price Performance: 1.82%
Average Trading Volume: 90,086
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$221.2M
See more insights into 1498 stock on TipRanks’ Stock Analysis page.